Figure 2.

Percent of people born between 1945 and 1965 testing anti-HCV positive (n=2,900) who completed steps in the testing-to-care continuum, Hepatitis Testing and Linkage to Care (HepTLC) initiative, 21 U.S. municipalities, 2012–2014^a–c

^aThe HepTLC initiative promoted viral hepatitis B and hepatitis C screening, posttest counseling, and linkage to care at 34 U.S. sites. Hepatitis C testing sites were located in San Diego, California; Denver, Colorado; Atlanta, Georgia; Bronx, Ellenville, Rochester, and Queens, New York; Durham, North Carolina; Philadelphia, Pennsylvania; Aguas Buenas, Caguas, and San Juan, Yabucoa, Puerto Rico; Bamberg, Cheraw, Fairfax, Florence, Mullens, Orangeburg, South Carolina; San Antonio, Texas; and Washington, D.C.

^bLine graph represents the percentage of all anti-HCV-positive people who completed each step of the testing-to-care continuum.

^cBar graph represents the percentage of people who completed each successive step of the testing-to-care continuum.

^dApproximately 20%–30% of HCV-infected individuals will clear the virus spontaneously.

anti-HCV = hepatitis C virus antibody

HCV = hepatitis C virus

RNA = ribonucleic acid